OGG1 and cancer: Since cancer intervention using cytostatic drugs alone is often ineffective, combination strategies using OGG1 inhibitors together with other cancer-selective or cytotoxic drugs should be rationalized and tested in preclinical cancer models to address the utility of OGG1 inhibitors for cancer treatment.